PMDAX
Price
$22.56
Change
+$0.05 (+0.22%)
Updated
Jul 31 closing price
Net Assets
1.57B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

PMDAX vs VSCIX

PMDAX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
PMDAX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMDAX is a Buy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. PMDAX (1.57B). VSCIX pays higher dividends than PMDAX: VSCIX (1.23) vs PMDAX (0.90). PMDAX was incepted earlier than VSCIX: PMDAX (15 years) vs VSCIX (29 years). PMDAX (1.14) is less costly to investors than VSCIX (0.03). PMDAX is a more actively managed with annual turnover of: 25.90 vs. VSCIX (17.00). PMDAX has a lower initial minimum investment than VSCIX: PMDAX (1000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. PMDAX (21.21). PMDAX return over 5 years is better than : 40.59 vs. VSCIX (35.13).
PMDAXVSCIXPMDAX / VSCIX
Total Expense Ratio1.120.033,733%
Annual Report Gross Expense Ratio1.140.033,800%
Fund Existence15 years29 years-
Gain YTD16.71914.591115%
Front Load6%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.57B189B1%
Annual Yield % from dividends0.901.2373%
Returns for 1 year21.2122.5894%
Returns for 3 years38.0743.4488%
Returns for 5 years40.5935.13116%
Returns for 10 years78.42156.0750%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C